MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
+152.16%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$163M
AUM Growth
–
Cap. Flow
+$163M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$70.3M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
$64.4M |
| 3 |
Merus
MRUS
|
$22.5M |
| 4 |
OBSV
ObsEva SA Ordinary Shares
OBSV
|
$6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
THOR
1
DELISTED
Synthorx, Inc. Common Stock
THOR
| $70.3M | 43.05% | +1,005,184 | New | +$70.3M |
|
|
2
Phathom Pharmaceuticals
PHAT
$864M
| $64.4M | 39.46% | +2,067,861 | New | +$64.4M |
|
|
3
Merus
MRUS
$4.98B
| $22.5M | 13.81% | +1,600,000 | New | +$22.5M |
|
|
OBSV
4
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $6M | 3.68% | +1,570,000 | New | +$6M |
|